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CopperBoth the aa3-type cytochrome c oxidase from Rhodobacter sphaeroides (RsCcOaa3) and the closely related bo3-
type ubiquinol oxidase from Escherichia coli (EcQObo3) possess a proton-conducting D-channel that
terminates at a glutamic acid, E286, which is critical for controlling proton transfer to the active site for
oxygen chemistry and to a proton loading site for proton pumping. E286 mutations in each enzyme block
proton ﬂux and, therefore, inhibit oxidase function. In the current work, resonance Raman spectroscopy was
used to show that the E286A and E286C mutations in RsCcOaa3 result in long range conformational changes
that inﬂuence the protein interactions with both heme a and heme a3. Therefore, the severe reduction of the
steady-state activity of the E286 mutants in RsCcOaa3 to ~0.05% is not simply a result of the direct blockage of
the D-channel, but it is also a consequence of the conformational changes induced by the mutations to heme a
and to the heme a3-CuB active site. In contrast, the E286C mutation of EcQObo3 exhibits no evidence of
conformational changes at the two heme sites, indicating that its reduced activity (3%) is exclusively a result
of the inhibition of proton transfer from the D-channel. We propose that in RsCcOaa3, the E286 mutations
severely perturb the active site through a close interaction with F282, which lies between E286 and the heme-
copper active site. The local structure around E286 in EcQObo3 is different, providing a rationale for the very
different effects of E286mutations in the two enzymes. This article is part of a Special Issue entitled: Allosteric
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Nearly all aerobic organisms contain at least one respiratory heme-
copper oxygen reductase. These membrane-bound proton pumps
catalyze the 4-electron reduction of O2 to two water molecules, andharness the free energy to pump four protons across the membrane
where they reside. In addition to the four pumped protons, four
additional protons are consumed by the oxygen chemistry, resulting
in the following overall reaction:
4e−1 + 8Hþin + O2→2H2O + 4H
þ
out
The majority of the heme-copper oxygen reductases can be
classiﬁed into the A, B and C families [1–3]. So far, most of the
biochemical and biophysical studies of heme-copper oxygen re-
ductases have been focused on a portion of the A-family, called the
A1-subfamily [3]. They include the aa3-type cyotochrome c oxidases
from mitochondria, Rhodobacter sphaeroides (RsCcOaa3) and Para-
coccus denitriﬁcans (PdCcOaa3), as well as the bo3-type ubiquinol
oxidase from Escherichia coli (EcQObo3). As a general rule, site-directed
mutants in the prokaryotic A1-family oxygen reductases from
P. denitriﬁcans, R. sphaeroides or E. coli, have similar phenotypes. In
the current work, it is shown that this is not the case for mutations in
E286, a residue at the top of the proton input D-channel, located near
1343T. Egawa et al. / Biochimica et Biophysica Acta 1807 (2011) 1342–1348the enzyme active site. Long range conformational changes are
induced by the E286Cmutation in the enzyme from R. sphaeroides but
not in the closely related oxygen reductase from E. coli.
X-ray crystallographic [4–8] and site-directed mutagenesis studies
[9–15] of the A1 oxygen reductases have led to the identiﬁcation of
two proton input channels, called the D- and K-channels. A third
putative proton-conducting channel, the H-channel, has been iden-
tiﬁed in the mammalian cytochrome oxidase [16], but appears to be
unique to this subgroup of enzymes [17].
From studies on prokaryotic oxygen reductases in the A1
subfamily, it is widely accepted that the D- and K-channels are not
redundant, but they operate during different phases of the catalytic
cycle [9]. For each oxygen turnover in the bacterial A1 oxygen
reductases, the D-channel delivers two protons to the active site for
the oxygen chemistry, as well as four protons to a proton loading site
for their translocation across the membrane [18,19]. The K-channel,
on the other hand, is responsible for the delivery of the remaining two
“chemical” protons required for the oxygen chemistry in the active
site [20].
The D-channel in all the A1 oxygen reductases runs from an
aspartate, near the protein surface, to a glutamic acid near the enzyme
active site. Hereafter, these residues will be referred as D132 and
E286, respectively, based on the numbering system of RsCcOaa3
(Fig. 1). Earlier studies showed that all mutational substitutions for
E286 in A1 oxygen reductases (except the most conservative
substitution, E286D) result in drastic loss of oxidase activity and
proton pumping efﬁciency (if there is sufﬁcient activity to measure
pumping) [11,21–23]. This loss of function has been reasonably
attributed to the inhibition of proton ﬂux through the D-channel to
the active site, thus preventing the conversion of O2 to water.
However, the E286Q mutant of RsCcOaa3 exhibits peculiar spectro-
scopic properties that are not simply accounted for by the blockage of
proton transfer via the D-channel [9,22]. In addition, the crystalFig. 1. Schematic illustration showing the position of E286 in RsCcO (PDB code: 1M56). Th
propionate groups of hemes a and a3 are indicated in the inset. This ﬁgure was prepared bstructure of the E286Q mutant shows signiﬁcant changes induced by
the mutation in regions of the protein that are distant from the site of
the mutation [24].
In the current work, the E286C and E286A mutants of RsCcOaa3,
which exhibit properties similar to those of the E286Q mutant [9,22],
were examined by resonance Raman spectroscopy, and compared to
the E286C mutant of EcQObo3. The data show that the E286C and
E286A mutations in RsCcOaa3 signiﬁcantly perturb both heme a and
heme a3, while the E286Cmutation in EcQObo3 does not introduce any
noticeable spectroscopic changes. The different phenotypes of the
same E286mutation in the two closely related enzymes are attributed
to a difference in the local structures in the immediate vicinity of
E286.
2. Materials and methods
2.1. Site-directed mutagenesis
The E286C and E286A mutations in subunit I were introduced
using the Quickchange site-directed mutagenesis kit (Stratagene)
using the following primers:
E286Cfor: 5′-GGTTCTTCGGCCACCCGTGCGTCTACATCATC GTGC-3′,
E286Crev: 5′-GCACGATGATGTAGACGCACGGGTGGCCGAAGAACC-3′,
E286Afor: 5′-GGTTCTTCGGCCACCCGGCGGTCTACATCATCGTGC-3′
and
E286Arev: 5′-GCACGATGATGTAGACCGCCGGGTGGCCGAAGAACC-3′.
The primers to introduce E286C in subunit I of cytochrome bo3
were E286Cfor: 5′-TTTGGGCCTGGGGCCACCCGTGCGTTTACATCCT-
GATCCTGCCTG-3′ and E286Crev: 5′-GCAGGATCAGGATGTAAACG-
CACGGGTGGCCCCAGGCCCAAATC-3′. The genes were partially
sequenced to verify the introduced mutations.e distances between E286 (that sits at the end of the D-channel) and the formyl and
y VMD software.
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Histidine-tagged wild type and mutant cytochrome oxidases were
expressed and puriﬁed from R. sphaeroides as described previously
[25]. Further puriﬁcation for proton pumpingwas done by fast protein
liquid chromatography using a DEAE-5PW column [26]. The histidine-
tagged wild type and mutant cytochrome bo3 enzymes were
expressed from E. coli C43 (DE3) strains and puriﬁed as described
previously [27].
2.3. Metal analysis
Metal content was measured by inductively coupled plasma
optical emission spectroscopy (ICP-OES) using a Spectro Genesis
spectrometer, as previously described [28]. In order to eliminate
adventitious divalent metals, the enzyme samples were dialyzed
overnight into 10 mM Tris–HCl, 20 mM KCl, 1 mM EDTA, and 0.05%
dodecylmaltoside at pH 8 prior to analysis. The method yields the
concentrations of Fe, Cu, Mg, Mn, Ca, Zn, Mo, and Ni as well as sulfur
and phosphorus. Measurements were made in triplicate and repro-
ducibility is within 5% using the same preparation. Results for the
R. sphaeroideswild type and mutant enzymes were normalized to the
calcium content, expected to be 1 calcium ion per oxidase molecule.
2.4. Steady-state kinetics
Steady-state activity was measured polarographically using a YSI
model 53 oxygen meter. The reaction mix contained 1.8 mL of 50 mM
potassium phosphate buffer pH 6.5 with 0.1% dodecylmaltoside,
10 mM ascorbate, 0.5 mM TMPD (N,N,N′,N′-tetramethylphenylene-
diamine) and 30 μM horse heart cytochrome c. The reaction mixture
for the oxygen reductase activity of cytochrome bo3 contained 1.8 mL
of 50 mM sodium phosphate buffer pH 6.5 with 0.05% dodecylmalto-
side, 10 mM dithiothreitol and 150 μM ubiquinone-1. Upon the
addition of oxidase, oxygen consumption was monitored and the
enzyme turnover number was calculated.
2.5. Resonance Raman spectroscopy
The resonance Raman spectra were obtained as previously
described [29]. Brieﬂy, the 413.1 nm excitation from a Kr ion laser
(Spectra-Physics, Mountain View, CA) was focused to a ∼30 μm spot
on the spinning quartz cell rotating at ∼1000 rpm. The scattered light,
collected at a right angle to the incident laser beam, was focused on
the 100 μm-wide entrance slit of a 1.25m Spex spectrometer equipped
with a 1200 grooves/mm grating (Bausch & Lomb, Analytical Systems
Division, Rochester, NY), where it was dispersed and then detected by
a liquid nitrogen-cooled CCD detector (Princeton Instruments,
Trenton, NJ). A holographic notch ﬁlter (Kaiser Optical Systems, Ann
Arbor, MI) was used to remove the laser line. The Raman shifts were
calibrated with indene. The concentrations of the RsCcOaa3 and
EcQObo3 were 50 and 30 μM, respectively. The laser powers used for all
Raman measurements are indicated in the captions.
3. Results
3.1. Catalytic activity
The steady-state activities of the E286C and E286A mutants of
RsCcOaa3 are b0.05% of the wild type level, similar to that reported for
the E286Q mutants of RsCcOaa3 (b1%) [9,22] and EcQObo3 (0.5%) [21].
The E286Cmutation of EcQObo3 shows that the quinol oxidase activity
is about 3% of the wild type level. Although this value (3%) is lower
than the previously reported value for the same mutant, 15% [21], it is
clear that the E286C mutant of EcQObo3 is considerably more active
than the E286C and E286A mutants of RsCcOaa3 (b0.05%).3.2. Optical absorption spectra
Fig. 2 shows the UV–Vis absorption spectra of the fully oxidized
and reduced forms of the wild type oxidase as well as the E286C and
E286A mutants of RsCcOaa3. In the fully reduced form of the wild type
enzyme, the absorption maxima of the Soret and visible bands are at
444 nm and 605 nm, respectively, as reported in the past [17]. The
E286C and E286A mutations lead to a blue-shift of the two bands to
441/601 nm and 442/602 nm, respectively. In the fully oxidized form
of the wild type enzyme, the absorption maxima of the Soret and
visible bands are at 424 nm and 600 nm, respectively. The E286C and
E286A mutations lead to broadening of these two bands.
Previous studies of the E286Q mutant of RsCcOaa3 show that it
exhibits an additional broad absorption near 595 nm in both the
oxidized and reduced forms as compared to the wild type enzyme
[9,22]. As evident in the E268C-minus-wild type difference spectra
shown in the inset of Fig. 2, the same “595 form” is also present in both
the oxidized and reduced forms of the E286Cmutant. It is noteworthy
that, although both difference spectra show additional features near
595 nm, the spectrum of the reducedmutant oxidases exhibits a sharp
band at 595 nm, while the spectrum of the oxidized enzyme shows a
broad feature with maxima at ~587 and 605 nm. Similar results were
obtained with the E286A mutant (data not shown). The data suggest
that the mutation of E286 in RsCcOaa3 to either A, C or Q perturbs the
heme structures in a similar fashion. It is notable that the 595 nm
band has been observed in other mutant preparations [9,22], as well
as in wild type oxidase derivatives [30,31]; its presence, combined
with Soret band shift, has been attributed to the presence of a minor
low-spin component of heme a3 in both oxidation states [9].
In sharp contrast to RsCcOaa3, the E286C mutant of EcQObo3
displays UV–Vis absorption spectra identical to those of the wild type
enzyme (data not shown), showing no indication that the structural
integrities of the hemes have been affected by the mutation.
3.3. Resonance Raman spectra
The perturbations in the heme structures in the E286C and E286A
mutants of the RsCcOaa3 were further investigated using resonance
Raman spectroscopy. Fig. 3 shows the resonance Raman spectra of the
wild type as well as the E286C and E286A mutants of RsCcOaa3 in the
fully oxidized state. The vibrational modes observed in this region of
the spectra (1300–1700 cm−1) are sensitive to the electronic and
structural properties of the hemes, such as the spin- and coordination-
states of the heme irons, the orientations of the peripheral groups
attached to the heme groups and the environment surrounding the
hemes. The assignments of these vibrational modes are well-
established. The porphyrin in-plane skeletal vibrations [32,33] and
the formyl stretching modes (νC=O) [34] of each heme in the wild
type enzyme are indicated in Fig. 3. The frequencies of the spin/
coordination state marker lines, ν2 and ν3, of heme a3 are at 1572 and
1480 cm−1, respectively, while those of heme a are at 1587 and
1502 cm−1, respectively. The spectrum of the wild type RsCcOaa3
conﬁrms that heme a3 and heme a are in the 6-coordinate high-spin
and 6-coordinate low-spin states, respectively, consistent with the
histidine/water axial ligations to heme a3 and the bis-histidine
coordination structure of heme a. In the spectra of the E286C and
E286Amutants, the intensity of the low-spin ν2 mode (1587 cm−1) is
signiﬁcantly increased at the expense of the high-spin ν2 mode
(1572 cm−1), as can be seen in the difference spectra at the bottom of
Fig. 3. Consistently, the intensity of the low-spin ν3 mode at
1502 cm−1 is enhanced with respect to the high-spin ν3 mode at
1480 cm−1. It is noted that, due to the broadening of the low-spin
line, this conversion is not readily apparent in the difference spectra.
Nonetheless, the data indicate that the mutations induce a partial
spin-conversion of heme a3 from high-spin to low-spin, implying the
coordination of a strong ﬁeld 6th ligand to the heme a3 iron in place of
Fig. 2. Optical absorption spectra of the wild type (wt), as well as the E286A and E286C mutants of RsCcOaa3, in their fully oxidized (A) and reduced states (B). The E286C-minus-wt
difference spectra of the E286C mutant in the oxidized and reduced states are shown in the inset in (A).
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modes of the formyl groups of both hemes a and a3 are also perturbed
by the mutations. Speciﬁcally, the intensity of the νC=O modes of
heme a and heme a3 at 1648 and 1672 cm−1, respectively, are
signiﬁcantly diminished. This is accompanied by an increase in the
Raman intensity at frequencies in between the two modes (see the
difference spectra, Fig. 3). The data indicate the broadening of the
formyl modes of heme a at 1648 cm−1 and heme a3 at 1672 cm−1, as
well as the up- and down-shift of the two modes, respectively, in the
mutants.
Fig. 4 shows the resonance Raman spectra of the wild type and the
E286C and E286A mutants of RsCcOaa3 in their fully reduced state.
Similar to the results in the oxidized state, an up-shift of the νC=O
mode of heme a (from 1610 to ~1630 cm−1) and concomitant down-
shift the νC=O mode of heme a3 (from 1662 to ~1630 cm−1) were
observed. They are associated with the reduction in the intensities of
the high-spin components from heme a3 at 1472 and 1567 cm−1,
indicating a partial high to low-spin conversion in the fully reduced
state.Fig. 3. Resonance Raman spectra of the oxidized forms of the wild type (wt), as well as
the E286C and E286A mutants, of RsCcOaa3. The E286C-minus-wt and E286A-minus-wt
difference spectra are shown at the bottom. The excitation wavelength for the Raman
measurements was 413.1 nm. The laser power at the sample was ~3 mW.Previous Raman studies indicated that three major factors may
modify the formyl vibrational mode of a-type heme: (1) the redox state
of the heme iron, (2) the electronic coupling between the formyl group
and the heme macrocycle, controlled by the relative orientation of the
formyl group with respect to the heme plane, and (3) the H-bonding
interactions between the formyl group and its surrounding protein
matrix [34,35]. In the ferrous form of thewild type RsCcOaa3, the formyl
group of heme a is strongly H-bonded to one or more groups in the
surrounding protein matrix, as indicated by its low νC=O frequency at
1610 cm−1 [35]. This is consistent with the crystallographic data
showing a strong H-bond between the formyl group and a conserved
arginine residue, R52 [4]. Upon oxidation, this mode shifts up by
36 cm−1, which is much larger than the ~25 cm−1 up-shift predicted
for a simple change in the oxidation state of the heme iron [34].
The additional ~11 cm−1 shift is an indication of an interruption of the
H-bonding interaction between the formyl group of heme a and R52. In
contrast to heme a, the formyl group of heme a3 is in a hydrophobic
environment and only very weakly H-bonded, as indicated by a very
high νC=O frequency in both oxidation states.Fig. 4. Resonance Raman spectra of the reduced forms of the wild type (wt), as well as
the E286C and E286A mutants, of RsCcOaa3. The E286C-minus-wt and E286A-minus-wt
difference spectra are shown at the bottom. The excitation wavelength for the Raman
measurements was 413.1 nm. The laser power at the sample was ~3 mW.
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E286 mutations lead to the up-shift and down-shift of the formyl
modes of heme a and heme a3, respectively, to ~1660 cm−1, a
frequency consistentwith that of ferric Heme A in an aqueous solution
(1660 cm−1) [34], in addition to the broadening of the two modes. In
the ferrous state, similar structural changes are apparent as indicated
by the spectral broadening, as well as an up-shift and down-shift of
the formyl modes of heme a and heme a3, respectively, to
~1630 cm−1, a frequency in agreement with that of ferrous Heme A
in aqueous solution (1635 cm−1) [34]. It is notable that similar
spectral changes attributed to a related origin have been observed in
other RsCcOaa3 mutants, although with the lines better resolved [36].
Overall, the data indicate that (1) the H-bonding interaction between
the formyl group of heme a and R52 is interrupted, and (2) the formyl
group of heme a3 is exposed to a hydrophilic environment with one or
more H-bond(s) donating to it. Thus, these results suggest that the
E286 mutations in RsCcOaa3 cause the movement of both hemes a and
a3. The heme movement results in the perturbation of the protein
environment surrounding the formyl groups of both hemes, as well as
the partial conversion of the heme a3 from a high-spin to a low-spin
state, indicating a rearrangement of the CuB-heme a3 binuclear center.
In contrast to RsCcOaa3, the E286C mutation in EcQObo3 does not
introduce noticeable changes to the Raman spectra in the fully
oxidized state (Fig. S1 in the Supporting information). Although heme
b and heme o3 of EcQObo3 do not have formyl substituents, the
vibrational modes of all other heme peripheral groups, such as the
vinyls (~1620 cm−1) and propionates (~1200 cm−1) in the E286C
mutant show features similar to those of the wild type enzyme.
Similarly, in the fully reduced state, no apparent changes in the Raman
spectrum of the E286Cmutant can be identiﬁed (Figs. S2 and S3 in the
Supporting information). To further investigate any potential struc-
tural perturbations introduced by the E286C mutation in EcQObo3, the
resonance Raman spectra of the CO-bound reduced form was
examined. Among the vibrational modes examined, the νC–O mode
is expected to be the most sensitive to the structure of the CuB-heme
o3 binuclear center. As shown in Fig. S5 in the Supporting information,
in the CO isotope difference spectrum of thewild type enzyme, the νC–
O modes were identiﬁed at 1959 and 1869 cm−1 for 12C16O and
13C18O, respectively. The E286C mutation does not affect the νC–O
mode at all, indicating that the heme-bound CO in the mutant
experiences the native environment. Likewise, the E286Q mutation
does not introduce changes to the spectrum of the CO-complex (see
Figs. S4–S6 in the Supporting information). These data are similar to
those previously reported for the E286C and E286D mutants of
EcQObo3, in which only negligible changes were observed in the νC–O
mode of the heme o3-CO moiety, although minor changes were
evident in the νC–O mode of the CuB-CO moiety [37]. In sum, the data
conﬁrm that the active site of EcQObo3 is not signiﬁcantly perturbed by
the E286C or Q mutations.
3.4. Metal analysis
To examine if the metal centers are retained in the mutants, metal
analysis was performed as described in Section 2. Table 1 shows the
Ca, Cu and Fe content of the wild type and E286C mutant of RsCcOaa3.
Ideally, the metal contents should be normalized to the total content
of sulfur (from cysteine and methionine), but the S content is about
double what is expected, due to protein impurities. Consequently, theTable 1
Relative metal contents in the wild type and E286C mutant of RsCcOaa3. The data were
all normalized to calcium.
Ca Cu Fe Cu/Fe
Wild type 1 3.00 2.19 1.37
E286C 1 1.93 2.08 0.93results were normalized to the Ca content, which is unlikely to be
present in membrane protein contaminants. The data show that the
wild type enzyme contained Ca, Cu and Fe, with a ratio of 1:3.00:2.19,
consistent with the theoretical ratio (1:3:2). The E286C mutant, on
the other hand, showed a ratio of 1:1.93:2.08, indicating the loss of ~1
equivalent of Cu, most likely the CuB in the active site. Although the
possibility of the loss of one of the coppers from CuA cannot be
excluded, it is unlikely as it is much harder to displace CuA from the
enzyme than CuB. To our knowledge, so far there is no subunit I
mutation that removes one copper from CuA. Furthermore, it has been
shown that, when CuB is completely absent in the aa3 enzyme, CuA
remains intact [38]; mutations of ligands of the Mn center, which is
directly connected to CuA, do not affect CuA binding either [39]; in fact
even mutation of two direct ligands of CuA in subunit II, Met263 and
His160, leaves the CuA in place [40,41].
4. Discussion
Our data show that the E286 mutations in RsCcOaa3 cause (1) the
interruption of the H-bonding interaction between the formyl group
of heme a and R52; (2) the exposure of the formyl group of heme a3
from a hydrophobic to a new hydrophilic environment; (3) the partial
conversion of heme a3 from a high-spin to a low-spin state; and
(4) loss of copper (at least in the case of E286C). In contrast, resonance
Raman spectra indicate no structural perturbation to either heme b or
heme o3 due to the E286C mutation in the E. coli bo3-type oxygen
reductase.
These structural changes in RsCcOaa3 suggest the movement of
both heme a and heme a3, as well as the rearrangement of the CuB-
heme a3 binuclear center. It is conceivable that the loss of CuB triggers
one of its histidine ligands (H333 or H334) to coordinate to heme a3,
accounting for its high- to low-spin conversion. The observation that
the changes in spin-state occur in both oxidation states supports the
scenario that the non-native low-spin ligand is an intrinsic histidine,
instead of an exogenous ligand such as a hydroxide, which would not
be able to coordinate to the heme iron in the reduced state. The
structural changes plausibly trigger the changes in the protein
environment surrounding the formyl groups of heme a and heme a3.
As shown in Fig. 5, the interactions of E286 with its environment
are very different for these two enzymes. Most signiﬁcant in this
regard is F282 in RsCcOaa3, which is only 3.3 Å away from E286. (See
Fig. S7 in Supporting information for the residues and their distances
from the glutamate in RsCcOaa3, EcQObo3, PdCcOaa3 and bCcOaa3). F282
is two-residues away from H284, one of the CuB ligands in RsCcOaa3,
and as such, a mutation at E286 might inﬂuence the structure of the
binuclear center via conformational changes transmitted through
F282. This interaction is not present in the E. coli cytochrome bo3,
which does not have a phenylalanine at position 282. Instead, a
phenylalanine residue in EcQObo3, F112, is located in a different helix
and not adjacent to residues coordinated to CuB, which might disable
the communication mechanism.
Differences in the local interactions around E286 can also explain
the fact that perturbations at the active site have different inﬂuences
on the hydrogen bonding interactions of E286 in the R. sphaeroides
and E. coli enzymes. For example, a shift of the protonated carboxyl
νC=O mode of E286 from 1726 to 1730 cm−1 is observed by FTIR
difference spectroscopy upon photodissociation of CO from CO-bound
EcQObo3 [37], but this is not observed in equivalent experiments on
RsCcOaa3 [42]. Hence, there is a change in the immediate environment
around E286 induced by CO photodissociation of CO from the fully
reduced E. coli enzyme but not from the R. sphaeroides enzyme. These
FTIR experiments as well as the current work show that the structural
linkage between the heme-copper active site and E286 is different in
the two enzymes. Since the enzymes appear to function in the same
way, there is no indication that these differences are of functional
signiﬁcance.
Fig. 5. Comparison of the structural region near E286 in RsCcOaa3 (PDB: 2GSM) and EcQObo3 (PDB: 1FFT). The dashed lines show all of the interactions that are 3.5 Å or less from E286.
It is also noted that the orientation of E286 sidechain is rotated ~90° in the comparison of the two enzymes. The ﬁgure was made with PyMol Molecular Graphics Software (Delano
Scientiﬁc, LLC).
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has a low copper content. The blue shifts of both the Soret and α-
bands in the E286C and E286Amutants of RsCcOaa3 (Fig. 2) are similar
to that observed in a CuB-deﬁcient enzyme [38]. However, the copper
content of the E286A and E286Q mutants of RsCcOaa3 have not been
measured, and the X-ray structure [24] and electrochemical proper-
ties [22] of the E286Q mutant indicate the presence of CuB in at least
part of the population. The important point is that in the R. sphaeroides
enzyme, the E286 mutants result in extensive structural changes far
from the site of the mutation. This is conﬁrmed by the structure of the
E286Q mutant of RsCcOaa3 [24], which shows considerable long range
structural perturbations resulting from the E286Q mutation. In
particular, the position of the heme a3 moiety shifts by ~1 Å, thereby
disrupting the H-bonding interactions between the D-propionate of
the heme a3 and its surrounding protein environment [24]. However,
the structure also shows that CuB is retained in the binuclear center
and that no additional ligand occupies the distal ligand binding site of
heme a3 (i.e., high-spin heme a3 is expected). These data are
inconsistent with the spectroscopic data in the current work,
indicating the likely loss of CuB and the presence of 6-coordinate,
low-spin heme a3 in at least part of the population of the E286C
mutant of RsCcOaa3. One possible explanation is that only the sub-
population of E286Q that contains CuB is able to crystallize. It is clear
that the isolated E286Q mutant is heterogeneous [22]. Instability of
the mutants coupled to differences in enzyme preparative protocols
may also explain variability in the copper content.
The conformational changes induced by the E286A mutation can
be at least partially overcome by a second nearby mutation,
demonstrating how the local environment determines the phenotype
of the E286 mutations. This was demonstrated by the double mutant
E286A/I112E in RsCcOaa3 [43]. The I112E mutation places a carboxyl
group approximately where the E286 carboxyl is in the wild type
enzyme (see Fig. 1). This double mutant is about 5% active and pumps
protons. A second study examined the doublemutant F274Y/E278A in
PdCcOaa3 [44]. The F274Y mutation restores the activity of the E278A
mutant to about 9%, also with proton pumping. This double mutant
was inspired by the residues present in the caa3-type oxidase from
Rhodothermus marinus, where the position equivalent to E278 in
PdCcOaa3 is occupied by an alanine, and it appears that the nearby
tyrosine carries out the function of the missing glutamate [45]. Note
that F274 in PdCcOaa3 is equivalent to F282 in RsCcOaa3 (see Fig. 1),
which we are suggesting may be responsible for the E286 mutations
causing conformational alterations at the active site.Finally, the comparison of the high-resolution crystallographic
structures of the wild type and E286Qmutant of RsCcOaa3 [4,46] is the
basis of the suggestion that the protonation/deprotonation of E286
during catalysis might trigger a wide range of structural changes to
the enzyme [24], providing a mechanism for proton pumping. The
current work shows deﬁnitively that the conformational changes
resulting from E286 mutations are not universal, since they are not
observed in the proton pumping EcQObo3. Therefore, the model of
proton pumping [24] based on such conformational changes is not
likely to be correct.
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